Southern Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$766K Buy
5,961
+8
+0.1% +$936 0.32% 30
2026
Q1
$716K Hold
5,953
0.34% 33
2025
Q4
$627K Sell
5,953
-76
-1% -$7.13K 0.29% 42
2025
Q3
$506K Sell
6,029
-118
-2% -$9.72K 0.24% 46
2025
Q2
$487K Sell
6,147
-350
-5% -$27.8K 0.25% 47
2025
Q1
$583K Buy
6,497
+782
+14% +$73K 0.32% 39
2024
Q4
$569K Buy
5,715
+59
+1% +$6.08K 0.31% 40
2024
Q3
$642K Buy
5,656
+1,058
+23% +$126K 0.36% 34
2024
Q2
$569K Sell
4,598
-67
-1% -$8.63K 0.35% 39
2024
Q1
$616K Buy
4,665
+267
+6% +$32.9K 0.37% 34
2023
Q4
$479K Buy
4,398
+144
+3% +$14.9K 0.34% 36
2023
Q3
$438K Sell
4,254
-14,807
-78% -$1.6M 0.36% 39
2023
Q2
$2.2M Sell
19,061
-1,243
-6% -$141K 1.68% 14
2023
Q1
$2.16M Buy
20,304
+1,262
+7% +$136K 1.6% 15
2022
Q4
$2.11M Buy
19,042
+2,285
+14% +$234K 1.63% 17
2022
Q3
$1.44M Buy
16,757
+1,618
+11% +$144K 1.18% 19
2022
Q2
$1.38M Buy
15,139
+6,857
+83% +$608K 1.09% 22
2022
Q1
$680K Buy
8,282
+49
+0.6% +$3.86K 0.47% 32
2021
Q4
$631K Buy
+8,233
New +$656K 0.39% 37

Other funds holding MRK

Southern Capital Advisors's MRK Position: Q2 2026 in Review

Southern Capital Advisors increased its Merck (MRK) stake by 0.13% in Q2 2026, buying an estimated $936 and bringing the position to 5,961 shares worth $766K. The position accounts for 0.32% of the portfolio, ranked #30.

Southern Capital Advisors first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.2M in Q2 2023. 1,865 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Southern Capital Advisors held 5,961 shares of Merck worth $766K as of Q2 2026.
  • Southern Capital Advisors bought 8 Merck shares in Q2 2026, an estimated $936.
  • Merck made up 0.32% of Southern Capital Advisors's portfolio in Q2 2026, its #30 holding.
  • Southern Capital Advisors first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • Southern Capital Advisors's Merck position peaked at $2.2M in Q2 2023.
  • 1,865 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Southern Capital Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.